Literature DB >> 15999150

Influence of sialic acid removal on MUC1 antigenic reactivity in head and neck carcinoma.

María V Croce1, Martín E Rabassa, Adrián Pereyra, Amada Segal-Eiras.   

Abstract

To investigate the influence of sialic acid removal on MUC1 peptidic and carbohydrate epitope reactivity in head and neck squamous cell carcinoma (HNSCC), tumor samples belonging to 24 HNSCC patients were studied by standard immunohistochemistry (IHC) with and without desialylation with 0.1 U/ml neuraminidase. From each tumor sample, subcellular fractions were obtained and analyzed by SDS-PAGE and Western blotting (WB). Three monoclonal antibodies (MAbs) were used: C595 MAb directed to MUC1 protein core, an anti-Tn hapten MAb, and an anti-sTn hapten MAb; a comparative analysis between desialylated and sialylated samples was performed. By IHC without neuraminidase treatment, 19 of 24 samples reacted with anti-MUC1 peptidic epitope, while Tn hapten was not detected and sTn was found in 1 of 24 cases. Desialylation increased either the number of reacting cells or the intensity of the reaction with C595 and anti-Tn MAbs, and some negative samples became positive. On the other hand, sTn expression decreased with desialylation. By WB, several bands from >200 to 25 kDa were found; desialylation increased high-molecular-weight bands, diminishing the detection of low-molecular-weight ones. The use of desialylation is a suitable treatment that contributes to the exposure of MUC1-associated epitopes, which may be related to the spreading of HNSCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15999150     DOI: 10.1007/BF02893370

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  44 in total

Review 1.  Antigen retrieval techniques: current perspectives.

Authors:  S R Shi; R J Cote; C R Taylor
Journal:  J Histochem Cytochem       Date:  2001-08       Impact factor: 2.479

2.  Synthetic glycopeptides for the development of tumour-selective vaccines.

Authors:  Horst Kunz
Journal:  J Pept Sci       Date:  2003-09       Impact factor: 1.905

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.

Authors:  K O Lloyd; J Burchell; V Kudryashov; B W Yin; J Taylor-Papadimitriou
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

5.  Altered MUC1 and MUC2 glycoprotein expression in laryngeal cancer.

Authors:  J P Jeannon; F W Stafford; J V Soames; J A Wilson
Journal:  Otolaryngol Head Neck Surg       Date:  2001-02       Impact factor: 3.497

6.  Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.

Authors:  S Zhang; L A Walberg; S Ogata; S H Itzkowitz; R R Koganty; M Reddish; S S Gandhi; B M Longenecker; K O Lloyd; P O Livingston
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

7.  Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck.

Authors:  R W Farmer; W J Richtsmeier; R L Scher
Journal:  Head Neck       Date:  1998-12       Impact factor: 3.147

8.  Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.

Authors:  T Kjeldsen; H Clausen; S Hirohashi; T Ogawa; H Iijima; S Hakomori
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

9.  Electron-microscopic studies of the CA antigen, epitectin.

Authors:  M E Bramwell; G Wiseman; D M Shotton
Journal:  J Cell Sci       Date:  1986-12       Impact factor: 5.285

10.  Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.

Authors:  J Wesseling; S W van der Valk; H L Vos; A Sonnenberg; J Hilkens
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

View more
  3 in total

1.  Lewis x Antigen is Associated to Head and Neck Squamous Cell Carcinoma Survival.

Authors:  Martín E Rabassa; Adrian Pereyra; Liliana Pereyra; Amada Segal-Eiras; Martín C Abba; Maria V Croce
Journal:  Pathol Oncol Res       Date:  2017-07-05       Impact factor: 3.201

2.  MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.

Authors:  Martín E Rabassa; María V Croce; Adrián Pereyra; Amada Segal-Eiras
Journal:  BMC Cancer       Date:  2006-10-25       Impact factor: 4.430

3.  The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial.

Authors:  Donald T Weed; Serena Zilio; Isildinha M Reis; Zoukaa Sargi; Marianne Abouyared; Carmen R Gomez-Fernandez; Francisco J Civantos; Carla P Rodriguez; Paolo Serafini
Journal:  Front Immunol       Date:  2019-05-31       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.